Aclarion Announces Signing Of Commercial Agreement With Porter Hospital, An AdventHealth facility, To Bring Nociscan Technology To Denver
Portfolio Pulse from Benzinga Newsdesk
Healthcare technology company Aclarion, Inc. (NASDAQ: ACON) has announced a commercial agreement with Porter Hospital, an AdventHealth facility, to bring its Nociscan technology to Denver. Nociscan is a proprietary decision-support tool that helps physicians identify the location of chronic low back pain by quantifying chemical biomarkers associated with disc pain. The technology is expected to improve patient outcomes and reduce costs.
October 25, 2023 | 12:31 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Aclarion's agreement with Porter Hospital to bring its Nociscan technology to Denver could potentially increase the company's market presence and revenue.
The commercial agreement with Porter Hospital allows Aclarion to expand its footprint in Colorado, potentially increasing its customer base and revenue. The Nociscan technology, which helps physicians identify the location of chronic low back pain, could also gain more recognition and acceptance in the medical community, further driving demand for Aclarion's product.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100